Other OTC Pharmaceuticals - Burkina Faso

  • Burkina Faso
  • In Burkina Faso, the revenue generated in the market Other OTC Pharmaceuticals in 2024 is US$14.84m.
  • According to projections, this market is expected to experience an annual growth rate of 1.39% (CAGR 2024-2029).
  • When compared to global figures, the in the United States leads in revenue generation, with US$7,171.00m in 2024.
  • In terms of per capita revenue, each person in Burkina Faso contributes US$0.62 in 2024.
  • The demand for Other OTC Pharmaceuticals in Burkina Faso is driven by a growing awareness of self-medication and the availability of affordable and accessible healthcare options.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Burkina Faso is experiencing steady growth due to several factors.

Customer preferences:
Customers in Burkina Faso have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to the convenience and accessibility of these products, as they can be purchased without a prescription. Customers appreciate the ability to self-diagnose and treat minor ailments without having to visit a healthcare professional. Additionally, the affordability of OTC pharmaceuticals compared to prescription medications is also a key factor driving customer preferences.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Burkina Faso is the increasing demand for products related to pain relief and fever reduction. This can be attributed to the high prevalence of conditions such as headaches, body aches, and fevers among the population. As a result, analgesics and antipyretics are witnessing significant growth in sales. Another trend in the market is the rising demand for digestive health products. Burkina Faso has a cuisine that includes a variety of spices and flavors, which can sometimes lead to digestive issues. As a result, products such as antacids and digestive enzymes are gaining popularity among consumers.

Local special circumstances:
Burkina Faso is a landlocked country in West Africa with a growing population and improving healthcare infrastructure. However, access to healthcare facilities and professionals is still limited in some rural areas. This has led to an increased reliance on self-medication and OTC pharmaceuticals for minor health issues. The availability of OTC products in local pharmacies and small shops caters to this need and contributes to the growth of the market.

Underlying macroeconomic factors:
Burkina Faso has been experiencing steady economic growth in recent years, which has contributed to an increase in disposable income among the population. This has resulted in higher purchasing power and an ability to afford OTC pharmaceutical products. Additionally, the government's focus on improving healthcare services and infrastructure has also played a role in driving the growth of the Other OTC Pharmaceuticals market.In conclusion, the Other OTC Pharmaceuticals market in Burkina Faso is witnessing steady growth due to customer preferences for convenient and affordable healthcare solutions. The increasing demand for pain relief and digestive health products reflects the specific healthcare needs of the population. The local special circumstances, such as limited access to healthcare facilities, further contribute to the reliance on OTC pharmaceuticals. The underlying macroeconomic factors, including economic growth and government initiatives, also support the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)